1. Introduction and History of Melioidosis in the Philippines {#sec1-tropicalmed-03-00099}
=============================================================

Melioidosis, or Whitmore's disease, is a potentially lethal infection caused by the Gram-negative bacterium *Burkholderia pseudomallei*. Its clinical presentation is so diverse that the diagnosis relies heavily on laboratory culture.

During the past few decades, melioidosis has emerged as an important public health concern, especially in the South East Asian (SEA) region and northern Australia \[[@B1-tropicalmed-03-00099]\]. The increase in global interest in the disease was a consequence of the rising number of reported cases, both within endemic areas and among travelers, the occurrence of cases in areas not previously known to be endemic; and also, its potential use as an agent of bioterrorism.

After the disease was first described by Alfred Whitmore and C.S. Krishnaswami in 1912 \[[@B1-tropicalmed-03-00099],[@B2-tropicalmed-03-00099],[@B3-tropicalmed-03-00099]\], initially the majority of cases reported were from the SEA region. Reviews of the global distribution of the disease showed that cases have been found in the tropical and subtropical regions, mainly between 20° north and 20° south of the equator---which includes the Philippines \[[@B2-tropicalmed-03-00099],[@B4-tropicalmed-03-00099]\]. A recent modelling study suggested that there could be as many as 9000 cases and 4500 deaths, due to melioidosis occurring in the Philippines each year \[[@B5-tropicalmed-03-00099]\]. Certainly, nowhere near that number are being diagnosed, so how likely is this to be true?

The first documented case of human melioidosis in the Philippines occurred in 1948 in a 25-year-old American soldier who presented with weight loss and symptoms of pneumonia. Diagnosis was established through guinea pig inoculation of sputum and lymph node pus \[[@B6-tropicalmed-03-00099]\]. This was not long after the disease had first been recognized in countries like Vietnam \[[@B7-tropicalmed-03-00099]\] and Indonesia \[[@B8-tropicalmed-03-00099]\], and before the first indigenous case was described in Thailand \[[@B9-tropicalmed-03-00099]\]. However, in contrast to other SEA countries, there has been little development with regards to defining the epidemiology of the disease in the Philippines. A further case in an American soldier was reported in 1957, although his illness had started many years earlier, while he was stationed in the Philippines \[[@B10-tropicalmed-03-00099]\]. Sporadic cases were reported thereafter in people who had either transited or stayed in the country. Some of these individuals also had a history of travel to other parts of SEA, hence the evidence that the infection was acquired in the Philippines was inconclusive \[[@B2-tropicalmed-03-00099]\]. However, in others, such as the first case diagnosed in Taiwan in 1985, there was strong circumstantial evidence that infection was acquired in the Philippines during a near-drowning incident in a river near Manila \[[@B11-tropicalmed-03-00099]\].

Cases have not been limited to humans: For example, an isolate from a horse from the Philippines was included in a taxonomic study published in 1956, although no further clinical details are available about this case \[[@B12-tropicalmed-03-00099]\]. Then in 1992, a number of primates imported from the Philippines to the United Kingdom were involved in an outbreak of melioidosis \[[@B13-tropicalmed-03-00099]\]. However, there have been no other cases among animals from the Philippines reported in the literature thereafter.

Indigenous cases, meaning those with no apparent travel history to other endemic areas, and who were diagnosed and treated in the Philippines, had never been reported in the literature until 2002, when a 49-year-old farmer from Bulacan in the Philippines presented with pain and swelling of the left shoulder and was found to have melioidosis after *Burkholderia pseudomallei* was isolated from blood \[[@B14-tropicalmed-03-00099]\]. The second indigenous case, and the first case published in an international journal, was reported as recently as 2016 \[[@B15-tropicalmed-03-00099]\]. The patient was a farmer from Isabela with no history of travel outside the country, who was diagnosed and treated in a hospital in Metro Manila.

The preponderance of reports of melioidosis among travelers from the Philippines, and the paucity of indigenous cases, leads us to suspect that the disease is being grossly under-reported in the country. This article describes the evidence for, and distribution of, melioidosis in the Philippines by reviewing reports published in international and local publications and unpublished case reports that were obtained from tertiary hospitals and local subspecialty organizations. These cases were examined to determine common patient profiles, disease presentations, modes of diagnosis, treatment received, and outcomes.

2. Materials and Methods {#sec2-tropicalmed-03-00099}
========================

2.1. Review of Publications {#sec2dot1-tropicalmed-03-00099}
---------------------------

Published reports citing cases of culture-confirmed melioidosis from the Philippines were collected. The melioidosis website ([www.melioidosis.info](www.melioidosis.info)) served as the main starting point for the search, as it already contains a database of published case reports by country. In addition, PubMed and Google Scholar were searched, using various combinations of keywords (and MESH terms, where applicable) such as Philippines, Filipino, Southeast Asia, melioidosis, Whitmore's disease, *Burkholderia pseudomallei*, and *Pseudomonas pseudomallei*. The bibliography of each reference was searched for further cases. Finally, the personal EndNote database of one of us (DABD) was searched for references that had been missed. From each reference, relevant information about each case was extracted, such as age, sex, co-morbidities, risk factors, type of infection, mode of diagnosis, treatment received, outcome, country where diagnosed, and year of diagnosis.

2.2. Collection of Locally Published and Unpublished Cases from the Philippines {#sec2dot2-tropicalmed-03-00099}
-------------------------------------------------------------------------------

Local medical journals and university papers available in the National Library of the Philippines, different universities, and hospitals were searched for any mention of local cases of melioidosis. Inquiries regarding cases of melioidosis were made to the Philippine Society for Microbiology and Infectious Diseases, the Research Institute for Tropical Medicine, and other medical centers. Consent to use the data was obtained from the authors of unpublished case series and reports that were collected.

3. Results and Discussion {#sec3-tropicalmed-03-00099}
=========================

A total of 25 articles, either single case reports or case series, describing culture-confirmed melioidosis in the Philippines were collected ([Table 1](#tropicalmed-03-00099-t001){ref-type="table"} and [Table 2](#tropicalmed-03-00099-t002){ref-type="table"}). Of these 25 papers, only 11 were listed in the melioidosis.org database---although those not included had either been published or presented at international conferences recently (between 2015 and 2017). This also included four unpublished local reports which were obtained from different tertiary hospitals in Metro Manila. Only one of these reports related to a case of melioidosis in an animal \[[@B13-tropicalmed-03-00099]\].

A total of 41 human cases was included in these articles, with 18 cases involving travelers and 23 indigenous cases. Among the indigenous cases, 20 were from the four previously unpublished reports. Of these four unpublished papers, two were case series derived from a 3- to 5-year chart review of patients that were culture-positive for *B. pseudomallei* from their respective institution, and the other two were single case reports. Diagnosis was established via culture-based technique and VITEK among indigenous cases. No additional molecular confirmatory tests were performed for these specimens.

The patients were between the ages of 21 and 82 years, with a mean of 50.2 years ([Table 3](#tropicalmed-03-00099-t003){ref-type="table"}). The patients were predominantly (85.4%) male. This is consistent with the epidemiologic data from some other endemic areas \[[@B16-tropicalmed-03-00099],[@B17-tropicalmed-03-00099],[@B18-tropicalmed-03-00099]\]. Data on risk factors were limited, but only six patients were known to be working in the agricultural sector. Geographical data were available for 20 indigenous cases, where 11 were from areas with moderate to high rice production in the Philippines (Isabela, Pampanga, and Bulacan). [Figure 1](#tropicalmed-03-00099-f001){ref-type="fig"} shows the geographical distribution of the reported cases in the Philippines, and annual rice production per province. Although the number of cases in Metro Manila is inconsistent with the expected high incidence of melioidosis among rice farmers, the authors suspected that these patients had previous exposure to agricultural areas. In addition, the proximity and access to diagnostic facility could have caused the relatively higher proportion of cases in Manila. All the indigenous cases were diagnosed in tertiary hospitals in Metro Manila, which generally have better-equipped laboratory and diagnostic facilities than most provincial hospitals, and it is likely that many patients are going undiagnosed outside the city.

The most common co-morbidity was diabetes mellitus, comprising 58.5% of cases, followed by cardiovascular disease (which includes hypertension and coronary artery disease) at 26.82%. Diabetes mellitus is the most common co-morbidity and risk factor found in the literature \[[@B16-tropicalmed-03-00099],[@B38-tropicalmed-03-00099],[@B39-tropicalmed-03-00099]\]. With the steadily increasing prevalence of type 2 diabetes in the Philippines \[[@B40-tropicalmed-03-00099]\], it is likely that the incidence of melioidosis will increase correspondingly.

Pneumonia and soft tissue infection were present in 53.7% and 29.3% of cases respectively, which again is consistent with the melioidosis literature from elsewhere \[[@B17-tropicalmed-03-00099]\]. Pulmonary diseases, particularly pneumonia, chronic lower respiratory tract diseases, and tuberculosis, are among the top 10 causes of mortality in the Philippines \[[@B41-tropicalmed-03-00099]\]. Since melioidosis may be difficult to differentiate from other respiratory diseases, it is possible that many cases labelled simply as 'pneumonia' or other respiratory infections may actually have melioidosis. A high index of suspicion, and good laboratory support, are necessary to make a specific diagnosis of melioidosis. Furthermore, co-infection with *B. pseudomallei* and *Mycobacterium tuberculosis* was seen in two patients in this review, which presents a further diagnostic and therapeutic challenge to clinicians. Other than pulmonary cases, four neurological cases were reported among indigenous cases. Although, conclusions could not be drawn, due to limited number of cases, this should be subject for further investigation if this type of melioidosis occur more frequently in the country.

All cases were diagnosed by culture studies. Bacteremia was found in 41.5% of cases. The most common antibiotic used were ceftazidime and trimethoprim-sulfamethoxazole for the intensive phase and eradication phase, respectively. Most of the cases received the recommended antibiotic treatment for melioidosis \[[@B42-tropicalmed-03-00099]\] such as ceftazidime (43.59%), meropenem (12.82%), trimethoprim-sulfamethoxazole (53.84%), and amoxicillin-clavulanic acid (5.13%). Those treated with different antibiotics were cases diagnosed earlier than 1990s, and those indigenous cases which followed the result of the antibiotic sensitivity test. The reported recurrence rate among all cases were 4.9%, while the mortality rate was 12.6%. This, however, could be an underestimate due to lack of data and follow-up.

Failure to consider melioidosis, which requires specific treatment, may be contributing to the continued high mortality from pulmonary diseases in the Philippines. Local clinical guidelines do not include ceftazidime and meropenem as empiric treatment unless classified as high-risk community-acquired pneumonia, healthcare-associated pneumonia, or those at risk for multidrug-resistant organisms.

4. Challenges {#sec4-tropicalmed-03-00099}
=============

The greatest challenges for the Philippines are to raise awareness of melioidosis amongst clinicians and laboratory staff, and to improve the availability of facilities capable of making a laboratory diagnosis of the disease. During our enquiries with colleagues and local institutions about case reports, many of those who responded admitted to being unfamiliar with melioidosis. Also, melioidosis is rarely included in the curriculum of medical schools within the Philippines. It is notable that the majority of the earlier cases in this series were diagnosed in travelers to other countries, albeit only 21 cases occurring over 70 years, implying considerable under-diagnosis of indigenous cases. However, there are some encouraging signs, particularly, the fact that four unpublished reports, comprising 20 indigenous cases seen over a relatively short span of seven years, were identified. This suggests an increasing awareness of the disease among physicians, resulting in improved diagnosis and reporting. However, these were all diagnosed in Metro Manila, which is unlikely to be the area of highest incidence in a country where the environment is predicted to be widely suitable for *B. pseudomallei* \[[@B5-tropicalmed-03-00099]\], and the incidence of melioidosis in more rural areas requires further investigation. Areas such as those in Mindanao, which are a highly rural area, post additional challenge since access to health care facilities is another existing issue. However, this will require the strengthening of medical laboratories in these areas, and education of staff in how to detect and identify *B. pseudomallei*.

Although the most common presentation of *B. pseudomallei* infection is pneumonia, the 2016 community-acquired pneumonia (CAP) guidelines in the Philippines do not even mention melioidosis as a differential diagnosis. There is no national surveillance system for melioidosis, nor is the disease included in the list of notifiable disease in the Philippines \[[@B43-tropicalmed-03-00099]\].

5. Conclusions and Recommendations {#sec5-tropicalmed-03-00099}
==================================

This report highlights the fact that melioidosis is indeed endemic in the Philippines but is likely to be grossly under-reported. The clinical and epidemiological characteristics of the disease in the Philippines, albeit based on limited data, are consistent with those described in published literature from other countries. Furthermore, the data show that this condition has been successfully diagnosed and treated in the country with increasing frequency over the past few years.

Further studies should be done on the extent and impact of this disease within the country. It is recommended that a program of education of clinicians and laboratory staff about melioidosis should be initiated, ideally starting at medical schools, and especially targeted at rural areas that are likely to have the highest incidence of melioidosis. Furthermore, consideration should be given to making the disease statutorily notifiable. This would provide more accurate information about the clinical characteristics and distribution of the disease within the Philippines. Soil sampling studies should also be undertaken in order to establish the geographic distribution of this microorganism, as well as enable analysis of the population structure. Genotyping of bacterial isolates are in progress in order to determine if indigenous strains were different than those identified elsewhere in Southeast Asia or Australia. Studies should also be undertaken to describe the current knowledge and attitudes of Filipino clinicians regarding melioidosis.
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tropicalmed-03-00099-t001_Table 1

###### 

Clinical characteristics of culture confirmed cases of melioidosis in the Philippines from published case reports.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Year Published   Age   Sex   Place Diagnosed   Co-Morbidities/Risk Factors                                                                                                         Melioidosis Type                                Method of Diagnosis                                                              Antibiotics              Outcome     Reference
  ---------------- ----- ----- ----------------- ----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------- -------------------------------------------------------------------------------- ------------------------ ----------- -------------------------------------------------------
  1948             25    M     No data           No data                                                                                                                             Pulmonary                                       Sputum culture (guinea pig inoculation)                                          No data                  No data     Gutner and Fisher \[[@B6-tropicalmed-03-00099]\]

  1957             32    M     USA               No data                                                                                                                             Cutaneous/soft tissue                           Sputum culture (guinea pig inoculation); tissue (rib and femoral mass) culture   PEN, SD, STR, CLT, CHL   Recurrent   Prevatt and Hunt \[[@B10-tropicalmed-03-00099]\]

  1975             54    M     USA               Lung carcinoma                                                                                                                      Pulmonary                                       Sputum and bronchial washing cultures                                            TET, CHL                 Died        Mays and Ricketts \[[@B19-tropicalmed-03-00099]\]

  1976             21    M     USA               None                                                                                                                                Pulmonary                                       Sputum culture                                                                   PEN, KAN, SXT            Improved    John \[[@B20-tropicalmed-03-00099]\]

  1978             23    M     USA               None                                                                                                                                Pulmonary                                       Sputum culture                                                                   TET, CHL, KAN, SXT       Improved    Fuller et al. \[[@B21-tropicalmed-03-00099]\]

  1985             46    F     Taiwan            Drowning                                                                                                                            Pulmonary                                       Blood culture                                                                    CEF, AMK                 Improved    Lee et al. \[[@B11-tropicalmed-03-00099]\]

  1994             40    M     Canada            Diabetes mellitus                                                                                                                   Pulmonary                                       Sputum culture                                                                   CAZ                      Improved    Turner et al. \[[@B22-tropicalmed-03-00099]\]

  2002             49    M     Philippines       Diabetes mellitus                                                                                                                   Disseminated (joint, pulmonary)                 Blood culture                                                                    IPM, AMC, SXT            Improved    Ereno et al. \[[@B14-tropicalmed-03-00099]\]

  2008             64    M     USA               Diabetes mellitus, coronary artery disease, hypertension                                                                            Pulmonary, osteomyelitis                        Paraspinal abscess culture, PCR, isolate sent to CDC for confirmation            MEM, SXT                 Improved    Falade et al. \[[@B23-tropicalmed-03-00099]\]

  2009             61    M     USA               Metabolic syndrome                                                                                                                  Pulmonary                                       Blood culture and pleural fluid culture, PCR                                     IMP, TGC, SXT, DOX       Improved    Duplessis and Maguire \[[@B24-tropicalmed-03-00099]\]

  2010             45    F     Philippines       Diabetes mellitus                                                                                                                   Pulmonary                                       Blood culture                                                                    TZP, CLI, AZM            Died        Velasco et al. \[[@B25-tropicalmed-03-00099]\]

  2011             50    M     Brunei            Diabetes mellitus                                                                                                                   Liver, spleen, cellulitis                       Blood culture                                                                    No Data                  Improved    Pande et al. \[[@B26-tropicalmed-03-00099]\] ^1^

  2011             41    M     Brunei            Diabetes mellitus                                                                                                                   Cellulitis, pulmonary, liver                    Blood culture                                                                    No Data                  Improved    Pande et al. \[[@B26-tropicalmed-03-00099]\] ^1^

  2014             62    M     Canada            Diabetes mellitus, Sjogren syndrome, chronic kidney disease, Stevens-Johnson syndrome secondary to amoxicillin, schistosomiasis,\   Musculoskeletal                                 Blood culture and PCR                                                            LVX, MET, DOX, SXT       Improved    Chagla et al. \[[@B27-tropicalmed-03-00099]\]
                                                 warm autoimmune hemolytic anemia                                                                                                                                                                                                                                                                          

  2015             60    M     South Korea       None                                                                                                                                Pulmonary                                       Tissue (lung) and sputum culture                                                 No data                  Improved    Kim et al. \[[@B28-tropicalmed-03-00099]\]

  2015             68    M     USA               Diabetes mellitus, coronary artery disease, hypertension, paroxysmal SVT                                                            Splenic                                         Splenic abscess culture                                                          CAZ, DOX, SXT            Improved    Guo et al. \[[@B29-tropicalmed-03-00099]\]

  2016             44    M     Philippines       Diabetes mellitus                                                                                                                   Hepatic                                         Liver abscess culture                                                            MEM, SXT                 Improved    San Martin et al. \[[@B15-tropicalmed-03-00099]\]

  2016             67    F     USA               Diabetes mellitus, cardiovascular disease, tuberculosis                                                                             Mycotic aneurysm                                Blood culture, PCR, isolate sent to CDC for confirmation                         MEM, SXT                 Died        Hemarajata et al. \[[@B30-tropicalmed-03-00099]\]

  2017             60    M     USA               Diabetes mellitus, hypertension, dyslipidemia                                                                                       Fever, loss of appetite, myalgia, weight loss   Blood culture, isolate sent to CDC for confirmation                              CAZ, SXT                 Improved    Singh and Mahmood \[[@B31-tropicalmed-03-00099]\]

  2017             82    M     USA               Hypertension, hyperlipidemia, osteoarthritis                                                                                        Mycotic aneurysm                                Blood culture                                                                    CAZ                      Improved    Panginnikod et al. \[[@B32-tropicalmed-03-00099]\]

  2018             41    M     Japan             Unknown                                                                                                                             Pulmonary, septic arthritis (soft tissue)       Blood culture                                                                    DOR                      Died        Hadano et al. \[[@B33-tropicalmed-03-00099]\]
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

AMC = amoxicillin-clavulanic acid; AMK = amikacin; AZM = azithromycin; CAZ = ceftazidime; CEF = cephalothin; CHL = chloramphenicol; CLI = clindamycin; CLR = clarithromycin; CLT = chlortetracycline; DOR = doripenem; DOX = doxycycline; FEP = cefepime; IPM = imipenem; KAN = kanamycin; LVX = levofloxacin; MEM = meropenem; MET = metronidazole; PEN = penicillin; SD = sulfadizine; SXT = trimethoprim-sulfamethoxazole; TGC = tigecycline; TZP = piperacillin-tazobactam; CIP = ciprofloxacin. ^1^ These were Filipino cases diagnosed in Brunei. The infection could have been either be acquired from the Philippines or during their stay in Brunei.

tropicalmed-03-00099-t002_Table 2

###### 

Clinical characteristics of confirmed cases of melioidosis in the Philippines from unpublished case reports and series.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Year Diagnosed   Age   Sex   Co-Morbidities/Risk Factors                                Melioidosis Type                                               Culture Specimen                Antibiotics                                                                            Outcome     Reference
  ---------------- ----- ----- ---------------------------------------------------------- -------------------------------------------------------------- ------------------------------- -------------------------------------------------------------------------------------- ----------- --------------------------------------------
  2010             54    M     Diabetes mellitus                                          Pulmonary                                                      Sputum                          TZP, CLR                                                                               Improved    Masbang \[[@B34-tropicalmed-03-00099]\]

  2010             62    M     Diabetes mellitus, cardiovascular disease                  Disseminated (cutaneous/soft tissue, pulmonary)                Blood                           CAZ, SXT                                                                               Improved    Masbang \[[@B34-tropicalmed-03-00099]\]

  2010             55    M     Heavy alcohol consumption                                  Pulmonary, neurologic                                          Bronchial washing               MEM, CAZ, SXT                                                                          Improved    Masbang \[[@B34-tropicalmed-03-00099]\]

  2011             66    M     Squamous cell lung carcinoma, hypertension, heavy smoker   Pulmonary                                                      Sputum                          MEM, AMC                                                                               Improved    Masbang \[[@B34-tropicalmed-03-00099]\]

  2011             54    F     Diabetes mellitus, hypertension                            Pulmonary                                                      Blood                           FEP                                                                                    Improved    Masbang \[[@B34-tropicalmed-03-00099]\]

  2012             60    M     Hypertension                                               Pulmonary                                                      Sputum                          MEM, SXT                                                                               Improved    Masbang \[[@B34-tropicalmed-03-00099]\]

  2013             45    M     Diabetes mellitus                                          Neurologic                                                     Sputum                          MEM, CAZ, DOX                                                                          Improved    Masbang \[[@B34-tropicalmed-03-00099]\]

  2014             57    F     Lung adenocarcinoma, hypertension                          Pulmonary                                                      Blood                           CAZ, LVX                                                                               Died        Masbang \[[@B34-tropicalmed-03-00099]\]

  2014             38    F     Breast cancer                                              Pulmonary                                                      Endotracheal aspirate           CAZ                                                                                    Died        Masbang \[[@B34-tropicalmed-03-00099]\]

  2014             64    M     Hypertension                                               Cutaneous/soft tissue                                          Abscess                         CAZ                                                                                    No data     Masbang \[[@B34-tropicalmed-03-00099]\]

  2014             47    M     Cardiovascular disease                                     Pulmonary                                                      Sputum                          CAZ                                                                                    No data     Masbang \[[@B34-tropicalmed-03-00099]\]

  2014             59    M     Pulmonary tuberculosis                                     Pulmonary, cutaneous/soft tissue                               Blood, sputum, and wound swab   FEP, CLI, MEM, SXT, TB antibiotics (Isoniazid, Rifampicin, Ethambutol, Pyrazinamide)   Improved    Ocampo \[[@B35-tropicalmed-03-00099]\]

  2013             40    M     Diabetes mellitus,\                                        Disseminated (soft tissue, liver, intra-abdominal infection)   Abscess                         CAZ, SXT, DOX                                                                          Improved    Yap et al. \[[@B36-tropicalmed-03-00099]\]
                               poultry worker                                                                                                                                                                                                                                               

  2009             34    M     Diabetes mellitus                                          Pulmonary                                                      Blood                           CAZ, SXT                                                                               Improved    Santos \[[@B37-tropicalmed-03-00099]\]

  2008             36    M     Diabetes mellitus                                          Hepatic                                                        Abscess                         CAZ, SXT                                                                               Improved    Santos \[[@B37-tropicalmed-03-00099]\]

  2012             59    M     Diabetes mellitus                                          Disseminated (cutaneous, joint, pulmonary)                     Synovial fluid, wound swab      CAZ, SXT, DOX                                                                          Improved    Santos \[[@B37-tropicalmed-03-00099]\]

  2009, 2012       44    M     Diabetes mellitus                                          Soft tissue (parotid), neurologic (chronic and recurrent)      Abscess                         2009: CAZ, CIP,\                                                                       Recurrent   Santos \[[@B37-tropicalmed-03-00099]\]
                                                                                                                                                                                         2012: CAZ DOX, CHL ^1^                                                                             

  2009             50    M     Diabetes mellitus, hypertension, coronary artery disease   Pulmonary                                                      Pleural fluid                   CAZ, SXT, DOX                                                                          Improved    Santos \[[@B37-tropicalmed-03-00099]\]

  2011             43    M     Diabetes mellitus, hypertension                            Neurologic                                                     Frontal cortex abscess          CAZ, SXT                                                                               Improved    Santos \[[@B37-tropicalmed-03-00099]\]

  2009             58    M     Diabetes mellitus, hypertension                            Urinary tract, CKD                                             Urine                           CAZ, SXT                                                                               Improved    Santos \[[@B37-tropicalmed-03-00099]\]
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

AMC = amoxicillin-clavulanic acid; AMK = amikacin; AZM = azithromycin; CAZ = ceftazidime; CEF = cephalothin; CHL = chloramphenicol; CLI = clindamycin; CLR = clarithromycin; CLT = chlortetracycline; DOR = doripenem; DOX = doxycycline; FEP = cefepime; IPM = imipenem; KAN = kanamycin; LVX = levofloxacin; MEM = meropenem; MET = metronidazole; PEN = penicillin; SD = sulfadizine; SXT = trimethoprim-sulfamethoxazole; TGC = tigecycline; TZP = piperacillin-tazobactam; CIP = ciprofloxacin. ^1^ Case readmitted after three years, due to recurrence of melioidosis.

tropicalmed-03-00099-t003_Table 3

###### 

Summary of clinical characteristics of culture-confirmed cases of melioidosis in the Philippines.

  Clinical Characteristics     Number of Cases
  ---------------------------- -----------------
  **Mean Age**                 50.2
  **Sex**                      
   Male                        35 (85.4%)
   Female                      6 (14.6%)
  **Comorbidities**            
   Diabetes mellitus           24 (58.5%)
   Cardiovascular disease      11 (26.82%)
   Cancer                      4 (9.76%)
   Pulmonary tuberculosis      2 (4.9%)
   Chronic kidney disease      1 (2.4%)
   Drowning                    1 (2.4%)
   Heavy alcohol consumption   1 (2.4%)
   Hyperlipidemia              1 (2.4%)
   Osteoarthritis              1 (2.4%)
  **Organs involved**          
   Pulmonary                   22 (53.7%)
   Soft tissue                 12 (29.3%)
   Hepatic                     5 (12.2%)
   Neurologic                  4 (9.76%)
   Splenic                     2 (4.9%)
   Mycotic aneurysm            2 (4.9%)
   Osteomyelitis               1 (2.4%)
  **Positive cultures**        
   Blood                       17 (41.5%)
   Respiratory (sputum)        16 (39.0%)
   Abscess pus                 7 (17.1%)
   Wound swab/Tissue           3 (7.3%)
   Synovial fluid              1 (2.4%)
  **Outcome**                  
   Improved                    22 (53.7%)
   Relapsed                    2 (4.9%)
   Died                        6 (14.6%)
   No Data                     5 (12.2%)
